Health Canada inspection
Daiichi Sankyo Pharma Canada Limited: Health Canada inspection of Jun 11, 2026
Health Canada · GVP · rating C
Key facts
| Establishment | Daiichi Sankyo Pharma Canada Limited |
|---|---|
| City | Toronto |
| Province | Ontario |
| Country | Canada |
| Program | GVP |
| Start date | Jun 10, 2026 |
| End date | Jun 11, 2026 |
| Rating | C |
| Rating description | Compliant |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.
Source: Health Canada, Drug and Health Product Inspections. Contains information licensed under the Open Government Licence – Canada · Source date: